Your prediction
Novozymes A/S B Stock
We can see a decrease in the price for Novozymes A/S B. Compared to yesterday it has lost -€1.140 (-2.010%).
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | -2.010% | 4.862% | 4.705% | 3.037% | 1.607% | 16.646% | 18.813% |
| Solvay S.A. A | -0.070% | 1.042% | 0.519% | -9.200% | -0.659% | -74.029% | -73.689% |
| Eastman Chemical Co. | -0.100% | 6.191% | 5.732% | -31.102% | 8.349% | -30.233% | -34.952% |
| Henkel AG & Co. KGaA VZO | 0.250% | 2.344% | 2.315% | -15.146% | 2.520% | 10.836% | -19.928% |
